Roseville, MN – Friday, June 17, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, participated recently at the annual investor conference, “LD Micro Invitational.” Speaking on behalf of Calyxt was President and CEO Michael A. Carr.
|Calyxt, Inc @ the LD Micro Invitational|
|Date:||Wednesday, June 8, 2022|
|Time:||10:30 a.m. ET (7:30 a.m. PT)|
|Webcast:||Link to view event|
The presentation is available for viewing and replay on the link above.
To schedule or learn about additional investor conversations with Calyxt, please reach out to firstname.lastname@example.org.
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers’ materials and products. As plant-based solutions, the Company’s synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, and the Calyxt logo are trademarks of Calyxt, Inc.
|Calyxt Media Contact:||Calyxt Investor Relations Contact:|
|Brennan Burks/ David Rosen/ John Garabo/ Michael Barron|
Calyxt Communications/Argot Partners
|Kimberly Minarovich/ Cameron Willis |
|Calyxt Business Development Contact:|
Senior Vice President of Business Development